Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
February 2013 Volume 42 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 42 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion

  • Authors:
    • Daisuke Fujimoto
    • Yasuo Hirono
    • Takanori Goi
    • Kanji Katayama
    • Shigeru Matsukawa
    • Akio Yamaguchi
  • View Affiliations / Copyright

    Affiliations: First Department of Surgery, Faculty of Medicine and Division of Bioresearch Laboratories, University of Fukui, Fukui 910-1193, Japan, Centers for Advanced Research Support, University of Fukui, Fukui 910-1193, Japan
  • Pages: 565-573
    |
    Published online on: December 14, 2012
       https://doi.org/10.3892/ijo.2012.1738
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Cell motility proceeds by cycles of edge protrusion, adhesion and retraction. Whether these functions are coordinated by biochemical or biomechanical processes is unknown. Tumor invasion and metastasis is directly related to cell motility. We showed that stimulation of proteinase-activated receptor-1 (PAR1) can trigger an array of responses that would promote tumor cell growth and invasion. Thus, we examined aspects of PAR1 activation related to cell morphological change that might contribute to cell motility. We established a PAR1 stably transfected MKN45 gastric cancer cell line (MKN45/PAR1). We examined morphological changes, Rho family activation and overexpression of cytoskeletal protein in cells exposed to PAR1 agonists (α-thrombin and TFLLR-NH2). MKN45/PAR1 grows with an elongated and polarized morphology, extending pseudopodia at the leading edge. However, in the presence of PAR1 antagonist, MKN45/PAR1 did not show any changes in cell shape upon addition of either α-thrombin or TFLLR-NH2. Activated PAR1 induced RhoA and Rac1 phosphorylation, and subsequent overexpression of myosin IIA and filamin B which are stress fiber components that were identified by PMF analysis of peptide mass data obtained by MALDI-TOF/MS measurement. Upon stimulation of MKN45/PAR1 for 24 h with either α-thrombin or TFLLR-NH2, the distribution of both myosin IIA and filamin B proteins shifted to being distributed throughout the cytoplasm to the membrane, with more intense luminescence signals than in the absence of stimulation. These results demonstrate that PAR1 activation induces cell morphological change associated with cell motility via Rho family activation and cytoskeletal protein overexpression, and has a critical role in gastric cancer cell invasion and metastasis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1. 

Kurschat P and Mauch C: Mechanisms of metastasis. Clin Exp Dermatol. 25:482–489. 2000.

2. 

Rofstad EK: Microenviroment-induced cancer metastasis. Int J Radiat Biol. 76:589–605. 2000. View Article : Google Scholar : PubMed/NCBI

3. 

Bhujwalla ZM, Artemov D, Ballesteros P, Cerdan S, Gillies RJ, et al: Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed. 15:114–119. 2002. View Article : Google Scholar : PubMed/NCBI

4. 

Gatenby RA and Gawlinski ET: Mathematical models of tumour invasion mediated by transformation-induced alteration of microenvironmental pH. Novartis Found Symp. 240:85–96. 2001. View Article : Google Scholar : PubMed/NCBI

5. 

Xu L, Fukumura D and Jain RK: Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem. 277:11368–11374. 2002. View Article : Google Scholar

6. 

Lauffenburger DA and Horwitz AF: Cell migration: a physically integrated molecular process. Cell. 84:359–369. 1996. View Article : Google Scholar : PubMed/NCBI

7. 

Horwitz AR and Parsons JT: Cell migration - movin’ on. Science. 286:1102–1103. 1999.

8. 

Ballestrem C, Wehrle-Haller B, Hinz B and Imhof BA: Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration. Mol Biol Cell. 11:2999–3012. 2000. View Article : Google Scholar : PubMed/NCBI

9. 

Prins M and Otten HMM: Thrombosis and cancer. A short history of Trousseau’s syndrome. Thrombosis and Cancer. Lugassy G, Falanga A, Kakkar A and Rickles F: Taylor & Francis; London: pp. 1–10. 2004

10. 

Walz DA and Fenton JW: The role of thrombin in tumor cell metastasis. Invasion Metastasis. 14:303–308. 1994.PubMed/NCBI

11. 

Nierodzik ML and Karpatkin S: Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell. 10:355–362. 2006. View Article : Google Scholar : PubMed/NCBI

12. 

Coughlin SR: Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 3:1800–1814. 2005. View Article : Google Scholar : PubMed/NCBI

13. 

Hollenberg MD and Compton SJ: International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev. 54:203–217. 2002. View Article : Google Scholar : PubMed/NCBI

14. 

Steinhoff M, Buddenkotte J, Shpacovitch V, et al: Proteinase-activated receptors: transducers of proteinase-mediated signalong in inflamation and immune response. Endocr Rev. 26:1–43. 2005. View Article : Google Scholar : PubMed/NCBI

15. 

Ramachandran R and Hollenberg MD: Proteinases and signaling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol. 153(Suppl 1): S263–S282. 2008. View Article : Google Scholar : PubMed/NCBI

16. 

Nystedt S, Emilsson K, Wahlestedt C and Sundelin J: Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA. 91:9208–9212. 1994. View Article : Google Scholar : PubMed/NCBI

17. 

Chambers RC, Dabbagh K, McAnulty RJ, Gray AJ, Blanc-Brude OP and Laurent GJ: Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J. 333:121–127. 1998.PubMed/NCBI

18. 

Dawes KE, Gray AJ and Laurent GJ: Thrombin stimulates fibroblast chemotaxis and replication. Eur J Cell Biol. 61:126–130. 1993.PubMed/NCBI

19. 

Boire A, Covic L, Agarwal A, Jacques S, Sherifi S and Kuliopulos A: PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 120:303–313. 2005. View Article : Google Scholar : PubMed/NCBI

20. 

Even-Ram SC, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, et al: Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med. 4:909–914. 1998. View Article : Google Scholar : PubMed/NCBI

21. 

Even-Ram SC, Maoz M and Pokroy E: Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha beta 5 integrin. J Biol Chem. 276:10952–10962. 2001. View Article : Google Scholar : PubMed/NCBI

22. 

Van Aelst L and D’Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 11:2295–2322. 1997.PubMed/NCBI

23. 

Nobes CD and Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:53–62. 1995. View Article : Google Scholar : PubMed/NCBI

24. 

Seasholtz TM, Majumdar M, Kaplan DD and Brown JH: Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res. 84:1186–1193. 1999. View Article : Google Scholar : PubMed/NCBI

25. 

Zohn IE, Symons M, Chrzanowska-Wodnicka M, Westwick JK and Der CJ: Mas oncogene signaling and transformation require the small GTP-binding protein Rac. Mol Cell Biol. 18:1225–1235. 1998.PubMed/NCBI

26. 

Ridley AJ and Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:389–399. 1992. View Article : Google Scholar : PubMed/NCBI

27. 

Ridley AJ, Paterson HF, Johnston CL, Diekmann D and Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:401–410. 1992. View Article : Google Scholar : PubMed/NCBI

28. 

Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S and Yamaguchi A: The activation of proteinase-activated receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion. BMC Cancer. 10:4432010. View Article : Google Scholar : PubMed/NCBI

29. 

Ahn HS, Foster C, Boykow G, Stamford A, Manna M and Graziano M: Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol. 60:1425–1434. 2000.PubMed/NCBI

30. 

Dery O, Corvera CU, Steinhoff M and Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol Cell Physiol. 274:C1429–C1452. 1998.PubMed/NCBI

31. 

Van Obberghen-Schilling E, Vouret-Craviari V, Chen YH, Grall D, Chambard JC and Pouyssegur J: Thrombin and its receptor in growth control. Ann NY Acad Sci. 766:431–441. 1995.PubMed/NCBI

32. 

Seasholtz TM, Majumdar M and Brown JH: Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol. 55:949–956. 1999.PubMed/NCBI

33. 

Kozasa T, Jiang X, Hart MJ, et al: p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science. 280:2109–2111. 1998. View Article : Google Scholar : PubMed/NCBI

34. 

Hart MJ, Jiang X, Kozasa T, et al: Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science. 280:2112–2114. 1998. View Article : Google Scholar : PubMed/NCBI

35. 

Bresnick AR: Mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol. 11:26–33. 1999. View Article : Google Scholar : PubMed/NCBI

36. 

Warrick HM and Spudich JA: Myosin structure and function in cell motility. Annu Rev Cell Biol. 3:379–421. 1987. View Article : Google Scholar : PubMed/NCBI

37. 

Giannone G, Dubin-Thaler BJ, Rossier O, et al: Lamellipodial actin mechanically links myosin activity with adhesion-site formation. Cell. 128:561–575. 2007. View Article : Google Scholar : PubMed/NCBI

38. 

Wu D, Asiedu M and Wei Q: Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene. 28:2219–2230. 2009. View Article : Google Scholar

39. 

Robertson SP: Filamin A: phenotypic diversity. Curr Opin Genet Dev. 15:301–307. 2005. View Article : Google Scholar : PubMed/NCBI

40. 

Weihing RR: The filamins: properties and functions. Can J Biochem Cell Biol. 63:397–413. 1985.PubMed/NCBI

41. 

Cunningham CC: Actin structural proteins in cell motility. Cancer Metastasis Rev. 11:69–77. 1992. View Article : Google Scholar : PubMed/NCBI

42. 

Takafuta T, Saeki M, Fujimoto TT, Fujimura K and Shapiro SS: A new member of the LIM protein family binds to filamin B and localizes at stress fibers. J Biol Chem. 278:12175–12181. 2003. View Article : Google Scholar : PubMed/NCBI

43. 

van der Flier A, Kuikman I, Kramer D, et al: Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits. J Cell Biol. 156:361–376. 2002.PubMed/NCBI

44. 

Baldassarre M, Razinia Z, Burande CF, Lamsoul I, Lutz PG and Calderwood DA: Filamins regulate cell spreading and initiation of cell migration. PLoS One. 4:e78302009. View Article : Google Scholar : PubMed/NCBI

45. 

Hollenberg MD, Mokashi M, Leblond L and DiMaio J: Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis. J Cell Physiol. 169:491–496. 1996. View Article : Google Scholar

46. 

Badgwell DB, Lu Z, Le K, et al: The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of Stat3 and FAK/Rho signaling pathway. Oncogene. 31:68–79. 2012. View Article : Google Scholar : PubMed/NCBI

47. 

Betson M, Lozano E, Zhang J and Braga VM: Rac activation upon cell-cell contact formation is dependent on signaling from the epidermal growth factor receptor. J Biol Chem. 277:36962–36969. 2002. View Article : Google Scholar : PubMed/NCBI

48. 

Macfarlane SR, Seatter MJ, Kanke T, Hunter GD and Plevin R: Proteinase-activated receptors. Pharmacol Rev. 53:245–282. 2001.PubMed/NCBI

49. 

Bogatcheva NV, Garcia JG and Verin AD: Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc). 67:75–84. 2002. View Article : Google Scholar : PubMed/NCBI

50. 

Garcia JG, Pavalko FM and Patterson CE: Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol. 163:510–522. 1995. View Article : Google Scholar : PubMed/NCBI

51. 

Buhl AM, Johnson NL, Dhanasekaran N and Johnson GL: G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem. 270:24631–24634. 1995. View Article : Google Scholar : PubMed/NCBI

52. 

Majumdar M, Seasholtz TM, Buckmaster C, Toksoz D and Brown JH: A rho exchange factor mediates thrombin and Gα(12)-induced cytoskeletal responses. J Biol Chem. 274:26815–26821. 1999.PubMed/NCBI

53. 

Amano M, Ito M, Kimura K, et al: Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 271:20246–20249. 1996. View Article : Google Scholar : PubMed/NCBI

54. 

Kimura K, Ito M, Amano M, et al: Regulation of myosin phosphatase by Rho-associated kinase (Rho-kinase). Science. 273:245–248. 1996. View Article : Google Scholar : PubMed/NCBI

55. 

Kraynov VS, Chamberlain C, Bokoch GM, Achwartz MA, Slabough S and Hahn KM: Localized Rac activation dynamics visualized in living cells. Science. 290:333–337. 2000. View Article : Google Scholar : PubMed/NCBI

56. 

Small JV, Stradal T, Vignal E and Rottner K: The lamellipodium: where motility begins. Trends Cell Biol. 12:112–120. 2002. View Article : Google Scholar : PubMed/NCBI

57. 

Miki H, Suetsugu S and Takenawa T: WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J. 17:6932–6941. 1998. View Article : Google Scholar : PubMed/NCBI

58. 

Yamazaki D, Suetsugu S, Miki H, et al: WAVE2 is required for directed cell migration and cardiovascular development. Nature. 424:452–456. 2003. View Article : Google Scholar : PubMed/NCBI

59. 

Welch MD and Mullins RD: Cellular control of actin nucleation. Annu Rev Cell Dev Biol. 18:247–288. 2002. View Article : Google Scholar : PubMed/NCBI

60. 

Pollard TD and Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell. 112:453–465. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S and Yamaguchi A: The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion. Int J Oncol 42: 565-573, 2013.
APA
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., & Yamaguchi, A. (2013). The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion. International Journal of Oncology, 42, 565-573. https://doi.org/10.3892/ijo.2012.1738
MLA
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., Yamaguchi, A."The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion". International Journal of Oncology 42.2 (2013): 565-573.
Chicago
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., Yamaguchi, A."The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion". International Journal of Oncology 42, no. 2 (2013): 565-573. https://doi.org/10.3892/ijo.2012.1738
Copy and paste a formatted citation
x
Spandidos Publications style
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S and Yamaguchi A: The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion. Int J Oncol 42: 565-573, 2013.
APA
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., & Yamaguchi, A. (2013). The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion. International Journal of Oncology, 42, 565-573. https://doi.org/10.3892/ijo.2012.1738
MLA
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., Yamaguchi, A."The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion". International Journal of Oncology 42.2 (2013): 565-573.
Chicago
Fujimoto, D., Hirono, Y., Goi, T., Katayama, K., Matsukawa, S., Yamaguchi, A."The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion". International Journal of Oncology 42, no. 2 (2013): 565-573. https://doi.org/10.3892/ijo.2012.1738
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team